

04 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251104211483/en/Zetagen-Therapeutics-to-Present-Promising-Preclinical-Data-at-SABCS-Zeta-BC-007-Demonstrates-Superior-Tumoricidal-Activity-and-Survival-Benefit-in-Breast-Cancer-Model